Skip to main content
. 2024 Dec 24;42(4):319–329. doi: 10.3857/roj.2024.00262

Table 2.

Dose constraints and results from the optimized treatment plans for cases 1 and 2

Structure Dose constraints Case 1 Case 2
Target volume
 PTV V100% ≥95 (%) 94.57 73.52
Dmax (Gy) 49.69 49.43
CI 0.79 0.72
GI 4.36 4.07
GIlow 13.24 15.87
GIhigh 1.93 1.83
OARs (excluding cardiac adjacent structures)
 Spinal cord Dmax ≤14 (Gy) 2.98 6.73
D1.2mL ≤8 (Gy) 2.51 5.49
 Esophagus D5mL ≤15.4 (Gy) 0.25 9.86
 Stomach D5mL ≤22 (Gy) - 16.59
 Lung total RV7Gy ≤1,500 (mL) 70.54 423.22
 Liver RV11Gy ≤700 (mL) - 3.49
OARs (Including heart-related structures)
 Heart (excluding PTV) D50% (Gy) 1.31 7.23
 Aorta Dmax ≤20.0 (Gy) 5.06 19.82
 Left coronary artery Dmax ≤14.0 (Gy) 14.05 31.54
 Left atrium Dmax ≤4.4 (Gy) 12.05 -a)

PTV, planning target volume; V100%, percent volume receiving 100% of the prescribed dose at the structure; CI, conformity index; GI, gradient index; GIlow, GI for low dose; GIhigh, GI for high dose; OAR, organ-at-risk; RV, reverse volume; Dmax, maximum dose irradiated to the structure; D1.2mL/D5mL, dose irradiated to 1.2ml/5ml of the structure; RV7Gy/RV11Gy, normal tissue volume receiving < 7 Gy/11 Gy; D50%, dose irradiated to 50% of volume of the structure.

a)

Target overlapped with the left atrium.